Khadir Raddassi

Khadir Raddassi is an Assistant Professor Adjunct in the Department of Neurology at Yale School of Medicine. His work bridges immunological research with neurological disorders, particularly focusing on multiple sclerosis and autoimmune mechanisms.

His educational background includes:

• PhD from Paris XI University (1991)
• MS from Paris XI University (1987)
• BS from Hassan II University (1986)

Dr. Raddassi's research trajectory began with cellular immunology and signal transduction, evolving toward assay development, automation, and autoimmune disease therapy mechanisms. His medical research interests encompass Biological Therapy, Clinical Protocols, and Immune System Diseases, while his public health interests include Biomarkers, Health Care Management, Vaccines, Immunology, and Influenza. His work demonstrates strong translational potential with clinical applications.

Analysis of Dr. Raddassi's recent publications reveals a research program spanning multiple sclerosis immunology, advanced immunological techniques like CyTOF, and significant contributions to understanding COVID-19 immunopathology. His 2025 publication on transcriptomic changes following B-cell depletion in MS patients demonstrates continued relevance in neuroimmunology, while his methodological work on FlowSOM clustering optimization shows technical expertise in immunological data analysis.

Dr. Raddassi maintains active research collaborations, most prominently with Dr. David A. Hafler, a leading neuroimmunology expert, as well as with infectious disease researchers including Albert Ko, Charles Dela Cruz, and Nathan Grubaugh. His work appears in high-impact journals including the Journal of Clinical Investigation, Frontiers in Immunology, and Nature Communications.